-
Carolyn Hax: Mom dumped stepdad and wants to coo about her new love to her kid
Mom dropped the letter writer’s stepdad for her college friend — and wants her kid to be as happy about it as she is.
-
Ask Amy: I’m miserable with my wife. I keep thinking about my ex.
A reader is stuck in an unhappy marriage and misses his ex-wife from over 30 years ago.
-
How the U.K.’s Economy Became So Stagnant
After more than a decade of deep budget cuts, slow growth and weak productivity, the country has struggled to overcome years of uncertainty and underinvestment.
-
Investor Support for Toyota Chairman Akio Toyoda Tumbles
A relatively low 71.9 percent of shareholders supported Akio Toyoda, who has faced scrutiny over governance issues, in his bid to remain chairman.
-
How Marco Rubio went from rival to one of Donald Trump’s VP finalists
Rubio is a finalist to be Trump’s running mate, the culmination of a years-long shift that has stunned and disappointed some of the senator’s former associates.
-
Exploring the Intersection of Love and Technology The Rise of Online Dating in the Digital Age
Love has been a timeless and universal human experience, one that has been celebrated and explored through art, literature, and music for centuries. But with the advancement of technology in the digital age, love has found a new intersection – the world of online dating. Gone are the days of meeting potential partners through chance…
-
What’s it to You? Justice Scalia’s 41-Year-Old Gatekeeping Question on “Standing” Influences Court to Uphold FDA’s Regulation of Mifepristone
Mifepristone is safe for now. On June 13, 2024, the Supreme Court unanimously held that the plaintiffs — doctors and medical associations alike — lacked standing to challenge 2000 and 2019 FDA approvals of mifepristone (brand name: Mifeprex), a drug used to terminate pregnancies through ten weeks gestation. Avoiding a substantive decision on the merits…
-
Developments Toward Standardizing AI ‘Red Teaming’
AI “red teaming” involves simulating attacks on AI systems to uncover vulnerabilities and enhance security. It is becoming an increasingly important practice, as regulatory frameworks—such as the National Institute of Standards and Technology (NIST) AI Risk Management Framework (AI RMF)—emphasize the importance of red teaming….By: Fenwick & West LLP
-
Spotlight On: Neulasta® (pegfilgrastim) / Fulphila® (pegfilgrastim-jmdb) / Udenyca® (pegfilgrastim-cbqv) / Ziextenzo® (pegfilgrastim-bmez) / Nyvepria®(pegfilgrastim-apgf) / Fylnetra™ (pegfilgrastim-apgf) / Stimufend® (pegfilgrastim-fpgk) – June 2024
Pegfilgrastim Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once. Within each IPR, claims are counted only…
-
Litigation Minute: State Statutes and the Private Right of Action (Generative AI Series: Part Two of Three)
What You Need To Know In A Minute Or Less – Class action litigation challenging generative artificial intelligence (AI) has rapidly become a familiar feature of the legal landscape. While early, headline-grabbing complaints were largely based on traditional theories of recovery, many of these have been dismissed, with courts commenting that the lawsuits presented “policy…
